Mefloquine monitoring in acute uncomplicated malaria treated with Fansimef and Lariam.
Southeast Asian J Trop Med Public Health
;
1993 Jun; 24(2): 221-5
Artigo
em Inglês
| IMSEAR
| ID: sea-35597
ABSTRACT
Mefloquine levels were compared between Plasmodium falciparum malaria patients with sensitive response and those with treatment failure who received 3 drug regimens of mefloquine (46 patients with MSP 3 tablets (Fansimef), 38 and 34 with mefloquine (Lariam) 750 mg and 1,250 mg). Mefloquine concentrations on Day-1 in any regimens in patients with treatment failure were significantly lower than those from the sensitive response, whereas there was no difference in the concentrations on Day-7. However, MIC values of mefloquine prior to drug treatment were comparable in both groups. The study suggests that pre-treatment in vitro sensitivity testing was a non-reliable indicator of clinical outcome. Mefloquine concentration on the first day after treatment is a better predictor of the treatment outcome.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Pirimetamina
/
Sulfadoxina
/
Humanos
/
Masculino
/
Mefloquina
/
Doença Aguda
/
Adolescente
/
Malária Falciparum
/
Adulto
/
Combinação de Medicamentos
Tipo de estudo:
Estudo prognóstico
Idioma:
Inglês
Revista:
Southeast Asian J Trop Med Public Health
Ano de publicação:
1993
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS